National Pharmaceutical Pricing Authority

Particulars
“Working Sheet Related to Price Notified on 20th December, 2013 regarding 24 Medicines.”
“NPPA has fixed / revised the prices in respect of 24 formulation packs both ceiling and non-ceiling under DPCO, 2013 and 56 formulations packs revised under DPCO, 1995 in order to implement the directions given in review order passed by the Department of Pharmaceuticals against S.O. No. 1492(E), 1495(E) to 1498(E) dated 07.06.2013 in related Notification / order dated 20.12.2013.”
“Working Sheet Related to Price Notified on 2nd December, 2013 regarding 18 Medicines.”
“Statement of Overcharging and Recovery thereof Since inception of NPPA till 30th November, 2013″
“NPPA has fixed/revised the prices in respect of 18 formulation packs and 1 corrigendum order reg. S.O. 1552(E) dated the 14th June, 2013 relating to the ceiling price fixation of Promethazine Syrup, 5mg/5ml on 2nd December, 2013”
“NPPA has issued 2 corrigendum orders regarding S.O. No. 3338(E) dated 05.11.2013 regarding Paclitaxel Injection, 30mg/5ml and S.O. No. 3376(E) dated 05.11.2013 regarding Lignocaine HCl Injection, 1% on 22nd November, 2013”
“NPPA has issued one Letter 30(4)/2013/Div.III dt. 26.11.2013 reg. Monitoring of Production and availability of Scheduled Formulations and the Active Pharmaceuticals Ingredients (APIs) contained in the Scheduled formulations under DPCO, 2013”
“List of 99 medicines included in Schedule – I of DPCO, 2013 for which no information is available and prices could not be fixed/notified.“
“Working Sheet Related to Price Notified on 5th November, 2013 regarding 52 Medicines.”
“NPPA has fixed/revised the prices in respect of 63 formulation packs on 5th November, 2013”
“NPPA has amendment to the Internal Guideline No. 2/2012 dated 09.10.2012“
“NPPA has issued one Letter 19(15)/2013/DP/NPPA/Div.II dt. 22.10.2013 reg. Price fixation of New Drug as per the provisions of para 5 of DPCO, 2013”
“NPPA has issued one Gazette Notification regarding S.O. No. 2532(E) dated 21^stAugust, 2013, relating to Oral Poliomyelitis Vaccine (LA) Solution is kept in abeyance with immediate effect.”
“NPPA issued Partial Modification / amendment to Circular of Even no. 24.9.2013.”
“Statement of Overcharging and Recovery thereof Since inception of NPPA till 30th September, 2013″
“List of 55 medicines included in Schedule – I of DPCO, 2013 for which no information is available and prices could not be fixed/notified.“
NPPA intends to invite sealed quotations from suitable man-power supply Agencies for supply of Data Entry Operators, Young Professionals (Cost) & Young Professionals (Pharma).
“NPPA issued Circular regarding NPPA fixing time limit of 15 days from the date of notification for receipt of representation by Pharma Industry.”
“Working Sheet Related to Price Notified on 20th September, 2013 regarding 40 Medicines.”
“Year wise Break Up of overcharged amount recovered from Inception (August 1997) of NPPA to 2013-2014 (upto August 2013)”
“NPPA has fixed / revised the prices in respect of 43 formulation packs, one Corrigendum with respect to S.O. No. 1676(E) dated 14.6.2013 reg. Sulphacetamide Sodium Drops, 20% and one Withdrawal Notification No. S.O. 2534(E) dated 21.8.2013 under New DPCO, 2013, one notification Norms for Viaflex Container (PVC) with Two Ports and one notification of Sodium Chloride (0.9%w/v)+ Dextrose (5%w/v) Injection in compliance of directions given in line the review order passed by the Department of Pharmaceuticals on 19.11.2012 vide letter no. 31015/15/2011-PI.I in respect of S.O. No. 2710(E) dated 28.11.2011. (47 Notifications / orders dated 20.9.2013)”
“Year wise Break Up of overcharged amount recovered from Inception (August 1997) of NPPA to 2013-2014 (upto August 2013)”
“Revised NPPA intends to invite sealed quotations from suitable man-power supply Agencies for supply of Data Entry Operators, Young Professionals (Cost) & Young Professionals (Pharma).”
“Working Sheet Related to Price Notified on 21st August, 2013 regarding 9 Medicines.”
“NPPA has fixed / revised the prices in respect of 9 formulation packs and Three Corrigendum Orders regarding S.O. No. 1545(E) dated 14.6.2013 regarding Propofovl Injection 1% oil suspension, S.O. No. 1643(E) dated 14.6.2013 regarding Dopamine Hydrochloride Injection (40mg/ml) and S.O. No. 1675(E) dated 14.6.2013 regarding Neostigmine Injection (0.5mg/ml)under New DPCO, 2013 Notifications / orders dated 21.8.2013.”
“NPPA REVISED THE TERMS OF REFERENCE FOR SMS BASED HELPLINE FOR GENERIC/BRANDED MEDICINES REGARDING INVITES of EXPRESSION OF INTEREST (EOI) FOR OPERATING ALL INDIA SMS HELPLINE FOR GENERAL PUBLIC TO PROVIDE INFORMATION ON GENERIC/ BRANDED MEDICINES DATED 9th MAY, 2013.”
“Re-labeling/Re-printing/Re-packing of revised prices as per NPPA’s – Department has issued Circular No. 31011/17/2012-PI-II dated 8.8.2013 regarding Notification No. 22/2013-Central Excise dated 29.07.2013 by the Department of Revenue, Ministry of Finance, Government of India”
“Working Sheets Related to Price Notified on 28th June, 2013 regarding 51 Medicines, Price Notified on 5th July, 2013 regarding 25 Medicines and Price Notified on 22nd July, 2013 regarding 26 Medicines.”
“Statement of Overcharging and Recovery thereof Since inception of NPPA till 31st July, 2013″
“Working Sheet Related to Price Notified on 21st June, 2013 regarding 39 Medicines.”
“Working Sheet Related to Price Notified on 14th June, 2013 regarding 150 Medicines.”
“Re-labeling/Re-printing/Re-packing of revised prices as per NPPA’s – Notification under DPCO, 2013 – exemption notification by the Department of Revenue, Ministry of Finance, Government of India vide Notification No. 22/2013-Central Excise dated 29.07.2013 regarding.”
“NPPA has fixed / revised the prices in respect of 26 formulation packs Notification under New DPCO, 2013 and Two Withdraw Notification S.O No. 1818(E) dt. 21.6.2013 & S.O. No. 1692(E) dt. 14.6.2013 and also Two Order against Review Order reg. Pyrantel Pamoate & Metronidazole Benzoate+Norfloxacin Notifications / orders dated 22.7.2013”
“NPPA has fixed/revised the prices in respect of 25 formulation packs on 5th July, 2013”
“NPPA has fixed/revised the prices in respect of 51 formulation packs on 28th June, 2013”
“Re-labeling/Re-printing of revised prices as per NPPA’s – Notification regarding.”
“NPPA has fixed/revised the prices in respect of 40 formulation packs on 21st June, 2013”
“NPPA has fixed/revised the prices in respect of 151 formulation packs on 14th June, 2013”
“NPPA has fixed/revised the prices in respect of 6 formulation packs reg. Insulin on 14th June, 2013”
“NPPA has fixed/revised the prices in respect of 86 formulation packs on 10th June, 2013”
“NPPA INVITES OF EXPRESSION OF INTEREST (EOI) FOR OPERATING ALL INDIA SMS HELPLINE FOR GENERAL PUBLIC TO PROVIDE INFORMATION ON MEDICINES”
“RTI Act 2005-Designating of Appellate Authority”
“NPPA has fixed/revised the prices in respect of 42 formulation packs on 2nd May, 2013”
“NPPA has fixed/revised the prices in of respect of 1 bulk drug on 2nd May, 2013”
“Submission of data for pricing of NLEM-2011 drugs under National Pharmaceutical Pricing Policy 2012 (NPPP-12)- reg.”
“Statement of Overcharging and Recovery thereof Since inception of NPPA till 31st March, 2013″
“NPPA has fixed/revised the prices in of respect of 1 bulk drug on 1st April, 2013”
“Calling quotation for Annual Contract for providing two DLY (AC) Vehicle (i) Indica/ Wagan-R / (Hyundai i-10 (Model 2010 or above) & (ii) Swift (Dzire)/ Indigo (Model 2010 or above) of Contract basis to National Pharmaceutical Pricing Authority for the period one year“
“Statement of Overcharging and Recovery thereof Since inception of NPPA till 31st January 2013″
“National Pharmaceuticals Pricing Authority (NPPA) invites tender for Disposal of unserviceable / condemned staff car”
“National Pharmaceuticals Pricing Authority (NPPA) requires Seven Security Guards (Six for round the clock and one for 9.30 A.M. to 6 P.M.) for security purpose from 1.4.2013 to 31.3.2014”
“National Pharmaceuticals Pricing Authority (NPPA) invites quotations for Annual Maintenance Contract for the Computers, Printers, Server, UPS, Router & Switch Pins”
“Review Order No. 31015/10/2012-PI.I dated 15^th January, 2013 against the Review application dated 29^th November, 2012 by Torrent Pharmaceuticals Limited under para 22 of DPCO, 1995 in respect of Human Mistard® 40iu, Human Actrapid® 40iu, Human Mixtard® 50 40iu and Human Insulatard® 40iu manufactured by Torrent under license from Novo Nordisk India Private Limited (Insulin Formulations) and against the NPPA notification no. S.O. 2734(E) dated 16^th November, 2012.”

Last Page Updated: 22-08-2018

Note :Website Content Managed by National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Designed, Developed and Hosted by National Informatics Centre Services Inc.(NICSI)

Archive-2013